MK

Mounika Kokkerakani

Active Director Director DIN 11441668
DIN 11441668 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mounika Kokkerakani

Data last updated:

Mounika Kokkerakani is a Director at Oiasis Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11441668
Primary Designation Director
Industry Pharma
First Appointment 20 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Dec 20252025Active

Board colleagues of Mounika Kokkerakani

NameDINCompanyDesignation
Anusha Nallagonda11441667Oiasis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oiasis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mounika Kokkerakani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mounika Kokkerakani

Mounika Kokkerakani currently holds 1 directorship: Oiasis Pharmaceuticals Private Limited (Director, since 20 Dec 2025).

Mounika Kokkerakani was first appointed on 20 Dec 2025 as Director at Oiasis Pharmaceuticals Private Limited.

The current boards of Mounika Kokkerakani's companies include Anusha Nallagonda (Oiasis Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available